- Home
- MLGO vs ADCT Comparison
MLGO vs ADCT Comparison
Compare MLGO & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLGO
- ADCT
- Stock Information
- Founded
- MLGO 2018
- ADCT 2011
- Country
- MLGO China
- ADCT Switzerland
- Employees
- MLGO N/A
- ADCT N/A
- Industry
- MLGO EDP Services
- ADCT Biotechnology: Pharmaceutical Preparations
- Sector
- MLGO Technology
- ADCT Health Care
- Exchange
- MLGO Nasdaq
- ADCT Nasdaq
- Market Cap
- MLGO 139.5M
- ADCT 131.8M
- IPO Year
- MLGO N/A
- ADCT 2020
- Fundamental
- Price
- MLGO $18.45
- ADCT $1.24
- Analyst Decision
- MLGO
- ADCT Strong Buy
- Analyst Count
- MLGO 0
- ADCT 5
- Target Price
- MLGO N/A
- ADCT $7.75
- AVG Volume (30 Days)
- MLGO 33.1M
- ADCT 360.3K
- Earning Date
- MLGO 04-15-2025
- ADCT 03-27-2025
- Dividend Yield
- MLGO N/A
- ADCT N/A
- EPS Growth
- MLGO N/A
- ADCT N/A
- EPS
- MLGO N/A
- ADCT N/A
- Revenue
- MLGO $83,504,125.00
- ADCT $70,837,000.00
- Revenue This Year
- MLGO N/A
- ADCT $11.56
- Revenue Next Year
- MLGO N/A
- ADCT $17.03
- P/E Ratio
- MLGO N/A
- ADCT N/A
- Revenue Growth
- MLGO 643.57
- ADCT 1.84
- 52 Week Low
- MLGO $1.11
- ADCT $1.22
- 52 Week High
- MLGO $509.60
- ADCT $5.38
- Technical
- Relative Strength Index (RSI)
- MLGO 67.03
- ADCT 29.96
- Support Level
- MLGO $17.22
- ADCT $1.28
- Resistance Level
- MLGO $32.40
- ADCT $1.68
- Average True Range (ATR)
- MLGO 5.65
- ADCT 0.11
- MACD
- MLGO 1.25
- ADCT -0.05
- Stochastic Oscillator
- MLGO 54.01
- ADCT 3.88
About MLGO MicroAlgo Inc.
MicroAlgo Inc is divided into two segments Central processing algorithm services & Intelligent chips and services. The majority is from the Central processing algorithm services. which refer to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.